High serum levels of IL-18 are associated with intestinal inflammation [52] and transgenic mice are more prone to colitis [85], while IL-18 inhibition is protective in models of inflammatory bowel disease (IBS) [86]. This evidence concerns the gene IL18 and inflammatory bowel disease.